These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8957151)

  • 41. Helicobacter pylori and gastroduodenal disorders: new approaches for prevention, diagnosis and treatment.
    Kotloff KL
    Vaccine; 1996 Aug; 14(12):1174-5. PubMed ID: 8911016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunoproteomics of Helicobacter pylori--strategy for improvement of diagnostic tests and vaccine development].
    Roszczenko P; Jagusztyn-Krynicka EK
    Postepy Biochem; 2006; 52(4):424-34. PubMed ID: 17536512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helicobacter pylori vaccines spiral into the new millennium.
    Sutton P; Doidge C
    Dig Liver Dis; 2003 Oct; 35(10):675-87. PubMed ID: 14620614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Will a specific preventive or curative vaccine for gastroduodenal ulcer be achieved?].
    Solano Aliende JA
    Rev Esp Enferm Dig; 1997 Jan; 89(1):46-7. PubMed ID: 9090981
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.
    Ghiara P; Rossi M; Marchetti M; Di Tommaso A; Vindigni C; Ciampolini F; Covacci A; Telford JL; De Magistris MT; Pizza M; Rappuoli R; Del Giudice G
    Infect Immun; 1997 Dec; 65(12):4996-5002. PubMed ID: 9393788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?
    Ruggiero P; Peppoloni S; Rappuoli R; Del Giudice G
    Microbes Infect; 2003 Jul; 5(8):749-56. PubMed ID: 12814776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori eradication: the rational treatment for peptic ulcer disease--chairmen's conclusion.
    Malfertheiner P; Deltenre M
    Scand J Gastroenterol Suppl; 1994; 205():59-60. PubMed ID: 7863243
    [No Abstract]   [Full Text] [Related]  

  • 48. Review article: Helicobacter pylori vaccines-the current status.
    Sutton P; Lee A
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1107-18. PubMed ID: 10971226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.
    Maleki Kakelar H; Barzegari A; Dehghani J; Hanifian S; Saeedi N; Barar J; Omidi Y
    Gastric Cancer; 2019 Jan; 22(1):23-36. PubMed ID: 30145749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic and clinical regimens against Helicobacter pylori infections in humans: an overview.
    Vyas SP; Sihorkar V; Kanaujia P; Jaitely V; Venkatesan N
    Pharmazie; 1999 Jun; 54(6):399-408. PubMed ID: 10399187
    [No Abstract]   [Full Text] [Related]  

  • 52. Status of vaccine research and development for Helicobacter pylori.
    Sutton P; Boag JM
    Vaccine; 2019 Nov; 37(50):7295-7299. PubMed ID: 29627231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach.
    Naz A; Awan FM; Obaid A; Muhammad SA; Paracha RZ; Ahmad J; Ali A
    Infect Genet Evol; 2015 Jun; 32():280-91. PubMed ID: 25818402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination against Helicobacter pylori.
    Lee A
    J Gastroenterol; 1996 Nov; 31 Suppl 9():69-74. PubMed ID: 8959525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccinating against Helicobacter pylori in the developing world.
    Zawahir S; Czinn SJ; Nedrud JG; Blanchard TG
    Gut Microbes; 2013; 4(6):568-76. PubMed ID: 24253617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.
    Rupnow MF; Owens DK; Shachter R; Parsonnet J
    Helicobacter; 1999 Dec; 4(4):272-80. PubMed ID: 10597398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in vaccine development against Helicobacter pylori.
    Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Helicobacter pylori CagA antigen antibodies].
    Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
    Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of Helicobacter pylori infections in gastric and duodenal ulcers].
    Svestka T
    Cas Lek Cesk; 2003 Aug; 142(8):483-6. PubMed ID: 14626564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.